Case-Control Study of a Novel Test for the Early Detection of Hepatocellular Carcinoma in at-risk Patients with Cirrhosis
- Sponsor:
- Curve Biosciences
- Sponsor Study ID:
- CRV-HCC-001
- CTO #:
- 104356
- NCT Number:
- NCT99999999
- Phase:
- N/A
- Protocol Type:
- Screening
- Age Group:
- Adults
- Disease Sites:
- Liver
- Study Objectives:
- To determine the diagnostic accuracy of the novel Hepatocellular Carcinoma (HCC) Test developed by Curve Biosciences in terms of area under the receiver operating characteristic curve (AUROC), sensitivity, and specificity for the differentiation of patients with HCC from those without HCC in the at-risk population.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Rockey, Don, at rockey@musc.edu
- Study Coordinator, Inman, Joshua, at inmanj@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina